Companies / Dare Bioscience, Inc.

Dare Bioscience, Inc.

Nasdaq: DARECIK 1401914SAN DIEGO, CA

Financials · FY2025

Revenue$1.03M
Net income$-13.40M
Total debt
Cash$12.62M
Diluted EPS$-1.20
Shares outstanding15.0M

Ownership

15.0M shares outstanding · as of May 13, 2026
7.3%Institutions
Ownership
Institutions7.26%1,088,074
Public float92.74%13,891,428

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Haring-Layton MarDeeChief Accounting Officer
Johnson Sabrina MartucciChef Executive Officer · Director

Institutional holders 28

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$107.7K+59K
+49.88%
177,839
1.19% of shares
low
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$99.8K+47K
+278.58%
64,248
0.43% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$50.4K+24K
+101.64%
47,415
0.32% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
TrimCommon Stock$-36.0K-20K
-59.80%
13,279
0.09% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
TrimCommon Stock$-16.6K-9K
-47.16%
10,195
0.07% of shares
low
Q2 2026
as of
LPL Financial LLC
13F manager
AddCommon Stock$528+250
+1.71%
14,889
0.10% of shares
low
Q4 2025
as of
Bank of America Corp /De
13F manager
TrimCommon Stock$-4-2
-1.53%
129
<0.01% of shares
low
Q1 2026
as of
Royal Bank of Canada
13F manager
NewCommon Stock$0+59
59
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DARECommon StockEquity23666P200BBG001J2P362